Dudediligence.

Cartesian Therapeutics, Inc

RNACNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$531,509

5 notices · 76,407 sh

Oct 2025 to Oct 2026

Reported ·

$258,683

3 sales · 1 buy · $205,800 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 3 reported sales carry the 10b5-1 box. Together they are 0.13% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-09: MILOS MILJKOVIC, Form 1442026-06-02: MILOS MILJKOVIC, Form 1442026-01-13: CHRISTOPHER M JEWELL, Form 1442026-01-09: CHRISTOPHER M JEWELL, Form 1442025-11-19: CHRISTOPHER M JEWELL, Form 1442025-12-04: BARABE TIMOTHY C, bought2026-01-06: Davis Blaine, sold2026-01-06: Miljkovic Milos, sold2026-01-06: Brunn Carsten, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-06-09MILOS MILJKOVIC, Chief Medical Officer$232,726
35,038 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-02MILOS MILJKOVIC, Chief Medical Officer$25,153
3,924 shno plan dateForm 4s on file end Jun 23144 ↗
2026-01-13CHRISTOPHER M JEWELL, Chief Scientific Officer$68,940
9,000 shno plan dateno Form 4 on file144 ↗
2026-01-09CHRISTOPHER M JEWELL, Chief Scientific Officer$12,105
1,510 shno plan dateno Form 4 on file144 ↗
2025-11-19CHRISTOPHER M JEWELL, Chief Scientific Officer$192,585
26,935 shno plan dateno Form 4 on file144 ↗